Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Senhwa Biosciences Silmitasertib Named as Potential COVID-19 Therapy 2020-03-31 19:00
China Pharma Holdings, Inc. Reports Fiscal Year 2019 Financial Results 2020-03-31 18:30
Yiling Pharmacy Lianhua Qingwen has been approved by the Ministry of Health of Thailand 2020-03-31 18:15
Fosun Pharma Announces 2019 Annual Results 2020-03-31 17:51
Hong Kong Hypnotherapist Launches Global App for De-stressing in the Time of Coronavirus 2020-03-31 15:30
3SBio Unveils 2019 Annual Results: Revenue Rises by 16.0%, Normalized Net Profit attributable to owners of the parent Jumps by19.4%, R&D Expenses Soar 45.2% 2020-03-31 12:29
Clarity appoints Dr Gillies O'Bryan-Tear to Chair Newly Formed Global Clinical Development Group 2020-03-31 12:10
Singapore-headquartered Telehealth Start-up Doctor Anywhere Closes US$27 Million Series B Financing Led by Square Peg, EDBI and IHH Healthcare 2020-03-31 10:00
Innovent Announces Financial Results for Full Year Ended December 31, 2019 and Corporate Progress 2020-03-31 00:08
INOVIO Interim Results of an Open-Label Phase 2 Trial of VGX-3100 Show Efficacy Against HPV-associated Vulvar Dysplasia 2020-03-30 21:00
OssDsign Receives Regulatory Approval and Prepares for Launch in Japan 2020-03-30 20:42
RavenPack Launches Free Coronavirus News Monitor to Help Data-driven Professionals Face the Challenging New Market Conditions 2020-03-30 20:00
Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use 2020-03-30 19:32
Alphamab Oncology, Simcere and 3D Medicines Announce Partnership to Develop and Commercialize Subcutaneous Injectable anti-PD-L1 Antibody for Oncology Indications in Mainland China 2020-03-30 19:00
SHL Medical acquires Weibel CDS 2020-03-30 14:00
CSPC Pharmaceutical Announces 2019 Annual Results 2020-03-30 12:34
Vela Diagnostics to offer manual ViroKey™ SARS-CoV-2 RT-PCR Test after completion of Emergency Use Authorization validation, targeted to be complete by early April 2020 2020-03-30 12:06
Nano Retina Announces Preliminary Results for First-in-Human Implantation of Its NR600 Artificial Retina Device 2020-03-30 08:00
Ascentage Pharma Releases 2019 Annual Results, Reports Increased Investment in R&D and Advances in Global Clinical Development 2020-03-30 08:00
GenScript ProBio Congratulates XlifeSciences on the Start of TAEST16001 Early Phase Clinical Trial 2020-03-27 21:00
1 602 603 604 605 606 979